“…Three genes previously considered suitable for clinical screening were now only recommended for research, whereas 10 other stroke-genes were strengthened and now fulfill the criteria for clinical testing. Smuk et al report novel phenotypic insights from genome sequencing of epilepsy genes [13] and Boonsimma et al treatment implications from exome testing in epilepsy [14].…”